MONTREAL, QUEBEC -- (MARKET WIRE) -- November 20, 2006 -- Yves Rosconi, President and CEO of Theratechnologies (TSX: TH), told attendees at the BioNorth Conference in Ottawa earlier today that the evolution of pharmaceutical industry is creating exciting new opportunities for Canadian biotech companies. He spoke of growing interest on the part of established pharmaceutical companies in biotech products, which are typically aimed at smaller niche markets. Mr. Rosconi said that this trend is strengthening the negotiating hand of biotech companies and giving them more options to develop their businesses.
